| Author(s)/Faculty: Dunya M. Atisha, MD; Scott T. Hollenbeck, MD; Irene Pien, MS | |||
| Type: Slides/Audio Lecture | |||
| Release Date: 5/15/2013 | Expiration Date: 5/14/2016 | ||
| Credit Type: CME/Participation | Number of Credit(s): 0.50 | ||
Sponsorship Statement: This continuing medical education activity is sponsored by .
Support Statement: There is no commercial support for this activity.
Target Audience: The intended audience for this activity is plastic surgeons and other healthcare professionals involved in treatment of plastic surgery patients.
Learning Objectives: At the conclusion of this activity participants should be able to:
- Understand the basic knowledge regarding the obesity epidemic in the United States.
- Understand the risks associated with obesity and breast reconstruction as it pertains to overall and surgical complications.
- Understand the differences in expander/ implant reconstruction and TRAM flap reconstruction as it pertains to breast reconstruction.
- Understand the technical nuances associated with improving outcomes for breast reconstruction in obese patients.
Irene Pien, MS
Duke University School Of Medicine
Durham, NC
Dunya M. Atisha, MD
Duke University Medical Center
Division of Plastic and Reconstructive Surgery
Durham, NC
Scott T. Hollenbeck, MD
Duke University Medical Center
Division of Plastic and Reconstructive Surgery
Durham, NC
External Reviewer:
Seth R. Thaller, MD, DMD, FACS (Planning Committee)
This enduring material is approved for 3 years from the date of release, May 15, 2013 to May 14, 2016.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
Irene Pien, MS
No relevant financial relationships to disclose.
Dunya M. Atisha, MD
No relevant financial relationships to disclose.
Scott T. Hollenbeck, MD
No relevant financial relationships to disclose.
Mimis Cohen, MD, FACS, FAAP (Planning Committee)
No relevant financial relationships to disclose.
External Reviewer reports the following relationship(s):
Seth R. Thaller, MD, DMD, FACS (Planning Committee)
No relevant financial relationships to disclose.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.